AE
AEON Biopharma, Inc.
AEON · AMEX
$0.24 -2.15% (-$0.01)
1M +22.85%
Market Cap $10.6M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.19
21.2% downside
Current Price
$0.24
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AEON is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
-
N/A EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
57 /100
Average ROA 924.25%
Asset turnover 0.00x
ROIC 1,699.74%
Debt
9 /100
High Current ratio 0.54x
Int. coverage N/A
Net debt/EBITDA N/A
Stability
37 /100
Moderate EPS volatility 913.20%
Profitable years 0
Beta 0.65x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AEON
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Robert Bancroft
Employees
8
Headquarters
Irvine
Upcoming events
13 NOV
Earnings
Upcoming earnings report